IRIS
SILVESTRI, Carmela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.701
EU - Europa 836
AS - Asia 213
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.752
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.700
UA - Ucraina 230
TR - Turchia 120
IE - Irlanda 119
SE - Svezia 115
IT - Italia 105
DE - Germania 95
DK - Danimarca 86
FI - Finlandia 50
KR - Corea 46
SG - Singapore 38
FR - Francia 13
GB - Regno Unito 13
RO - Romania 6
CN - Cina 5
IN - India 4
NL - Olanda 2
RS - Serbia 2
CA - Canada 1
CL - Cile 1
EU - Europa 1
Totale 2.752
Salva come PNG Salva come JPEG
Città #
Jacksonville 228
Chandler 224
Fairfield 208
Dublin 119
Wilmington 107
Ashburn 99
Woodbridge 91
Houston 80
Cambridge 76
Seattle 69
Boardman 53
New York 50
Lawrence 46
Princeton 46
San Mateo 44
Ann Arbor 35
Turin 35
San Diego 17
Des Moines 12
Buffalo 7
Izmir 7
Norwalk 7
Porto 7
Centro 6
Beijing 5
Helsinki 5
London 4
Pune 4
Kilburn 3
North Bergen 3
San Jose 3
Amsterdam 2
Belgrade 2
Campobasso 2
Dallas 2
Los Angeles 2
Pesaro 2
Acton 1
Berlin 1
East Los Angeles 1
Hanover 1
Hounslow 1
La Canada Flintridge 1
Nashville 1
Ozzano Monferrato 1
Prescot 1
Serra 1
St. Petersburg 1
Toronto 1
Yeongdeungpo-gu 1
Totale 1.725
Salva come PNG Salva come JPEG
Nome #
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 88
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 78
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 78
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 75
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 74
Urinary catheters and biofilm formation 71
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 70
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 70
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 70
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 68
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 68
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 67
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 67
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 65
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 65
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 64
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 64
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 64
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 63
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 63
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 63
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 62
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 62
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 61
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 60
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 59
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 58
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci. 57
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 57
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 57
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 56
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 56
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 56
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 56
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 55
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 55
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes. 54
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 53
In vitro activities of tachyplesin III against Pseudomonas aeruginosa. 51
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 51
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 50
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 49
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 47
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 45
Prevalence of intestinal parasites among individuals with allergic skin diseases. 43
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 40
Totale 2.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 0 7
2019/2020274 4 0 44 0 46 1 46 1 48 2 2 80
2020/2021791 53 77 99 11 74 64 96 62 76 64 82 33
2021/2022365 34 76 2 3 4 37 22 14 21 62 17 73
2022/2023647 58 97 52 43 41 65 2 31 160 4 75 19
2023/2024286 66 8 19 56 62 63 5 5 0 2 0 0
Totale 2.805